Laserfiche WebLink
Previous editions are obsoleteform HUD-52515 (04/15) <br />Page 3 of 4 ref. Handbook 7420.8 <br />(3) The undersigned shall require that the language of this certification be included in the award documents for all subawards at all <br />tiers (including subcontracts, subgrants, and contracts under grants, loans, and cooperative agreements) and that all subrecipients <br />shall certify and disclose accordingly. <br />This certification is a material representation of fact upon which reliance was placed when this transaction was made or entered into. <br />Submission of this certification is a prerequisite for making or entering into this transaction imposed by section 1352, title 31, U.S. Code. Any <br />person who fails to file the required certification shall be subject to a civil penalty of not less than $10,000 and not more than $100,000 for <br />each such failure. <br />Certification Regarding Drug-Free Workplace Requirements <br />Instructions for Drug-Free Workplace Requirements Certification: <br />1. By signing and/or submitting this application or grant agreement, the grantee is providing the certification set out below. <br />2. The certification set out below is a material representation of fact upon which reliance is placed when the agency awards the grant. <br />If it is later determined that the grantee knowingly rendered a false certification, or otherwise violates the requirements of the Drug-Free <br />Workplace Act, the agency, in addition to any other remedies available to the Federal Government, may take action authorized un der <br />the Drug-Free Workplace Act. <br />3. Workplaces under grants, for grantees other than individuals, need not be identified on the certification. If known, they may be <br />identified in the grant application. If the grantee does not identify the workplaces at the time of application, or upon award , if there is <br />no application, the grantee must keep the identity of the workplace(s) on file in its office and make the information available for Federal <br />inspection. Failure to identify all known workplaces constitutes a violation of the grantee’s drug-free workplace requirements . <br />4. Workplace identifications must include the actual address of buildings (or parts of buildings) or other sites where work un der the grant <br />takes place. Categorical descriptions may be used (e.g., all vehicles of a mass transit authority or State highway department while in <br />operation, State employees in each local unemployment office, performers in concert halls or radio studios). <br />5. If the workplace identified to the agency changes during the performance of the grant, the grantee shall inform the agency of the <br />change(s), if it previously identified the workplaces in question (see paragraph three). <br />6. Definitions of terms in the Nonprocurement Suspension and Debarment common rule and Drug-Free Workplace common rule apply <br />to this certification. Grantees’ attention is called, in particular, to the following definitions from these rules: <br />Controlled substance means a controlled substance in Schedules I through V of the Controlled Substances Act (21 U.S.C. 812) <br />and as further defined by regulation (21 CFR 1308.11 through 1308.15); <br />Conviction means a finding of guilt (including a plea of nolo contendere) or imposition of sentence, or both, by any judicial body <br />charged with the responsibility to determine violations of the Federal or State criminal drug statutes; <br />Criminal drug statute means a Federal or non-Federal criminal statute involving the manufacture, distribution, dispensing, use, or <br />possession of any controlled substance; <br />Employee means the employee of a grantee directly engaged in the performance of work under a grant, including: (i) All directcharge <br />employees; (ii) All indirectcharge employees unless their impact or involvement is insignificant to the performance of the grant; and, <br />(iii) Temporary personnel and consultants who are directly engaged in the performance of work under the grant and who are on the <br />grantee’s payroll. This definition does not include workers not on the payroll of the grantee (e.g., volunteers, even if used to meet <br />a matching requirement; consultants or independent contractors not on the grantee’s payroll; or employees or subrecipients or <br />subcontractors in covered workplaces). <br />A. The grantee certifies that it will or will continue to provide a drug-free workplace by: <br />(a) Publishing a statement notifying employees that the unlawful manufacture, distribution, dispensing, possession, or use of a controlled <br />substance is prohibited in the grantee’s workplace and specifying the actions that will be taken against employees for violation of such <br />prohibition; <br />(b) Establishing an ongoing drug-free awareness program to inform employees about: <br />(1) The dangers of drug abuse in the workplace; <br />(2) The grantee’s policy of maintaining a drug-free workplace; <br />(3) Any available drug counseling, rehabilitation, and employee assistance programs; and <br />(4) The penalties that may be imposed upon employees for drug abuse violations occurring in the workplace; <br />(c) Making it a requirement that each employee to be engaged in the performance of the grant be given a copy of the statement r equired <br />by paragraph (a); <br />(d) Notifying the employee in the statement required by paragraph (a) that, as a condition of employment under the grant, the employee <br />will: <br />(1) Abide by the terms of the statement; and <br />(2) Notify the employer in writing of his or her conviction for a violation of a criminal drug statute occurring in the workplace no <br />later than five calendar days after such conviction; <br />7-15